CIB, the NYSE-listed ADR for Grupo Cibest, reports quarterly results today after a week in which the stock has recovered most of the ground it lost in October, climbing 3% to $94.91. The options market remains conspicuously call-heavy. The put/call ratio of 0.33 is well below its 20-day average of 0.75, near the lowest reading of the past year at 0.26. That skew has persisted even…
CIB cost to borrow doubles to 0.43%, up 119% in one week, as short-selling demand tightens on the Colombian bank stock.
Key data as of 10 Nov 2026
CIB walks into today's print having already recovered from the dip that followed the August 3 report, closing at $91.47 Monday — up nearly 3% on the day and 10% higher over the past month — yet still trading well above…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CIB — free to start on ORTEX.
Sign up for free →Open CIB on ORTEX